Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data
JHVEPhoto Inspire Medical Systems (NYSE:INSP) and ResMed (NYSE:RMD) are both down significantly in Monday trading, apparent casualties of positive data released after the closing bell on June 21 of Eli Lilly’s (LLY) diabetes and weight loss drug tirzepatide as a sleep apnea treatment. Inspire manufactures an implantable neurostimulation device forContinue Reading